+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Amyloidosis Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • PDF Icon

    Report

  • 138 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5940364
Description Jump to:

Quick Summary:

In the rapidly evolving landscape of Amyloidosis Therapeutics, comprehending market dynamics is critical for senior executives shaping strategic decisions. Our meticulously crafted report provides an in-depth analysis of the industry, delivering insights that will inform your competitive approach and growth trajectories. Leveraging insights from key regions including North America, South America, Asia & Pacific, Europe, and MEA, this report is a lodestar for identifying emerging opportunities and navigating the complexities of the global market.

Gain a competitive edge with our exhaustive assessment of market trends, supply-demand shifts, and strategic outlook. Delve into detailed profiles of major and niche players, from industry giants like Pfizer Inc. and Alnylam Pharmaceuticals Inc. to innovative small-scale competitors, alongside critical SWOT analyses. Ground your tactics in solid data encompassing diverse applications such as AL, AA, and ATTR amyloidoses. Success in the Amyloidosis Therapeutics market hinges on informed decisions – let our report be the catalyst for your informed strategic planning.

This report describes the global market size of Amyloidosis Therapeutics from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • AL amyloidosis
  • AA amyloidoses
  • ATTR amyloidoses
  • Others

Companies Covered:

  • Pfizer Inc.
  • ProteoTech Inc.
  • Alnylam Pharmaceuticals Inc.
  • Arcturus Therapeutics Inc
  • Bellus Health Inc.
  • Bsim2
  • Celgene Corporation
  • Millennium Pharmaceuticals Inc.
  • Onyx Pharmaceuticals Inc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Amyloidosis Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Amyloidosis Therapeutics Market in North America (2019-2029)
8.1 Amyloidosis Therapeutics Market Size
8.2 Amyloidosis Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Amyloidosis Therapeutics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Amyloidosis Therapeutics Market in South America (2019-2029)
9.1 Amyloidosis Therapeutics Market Size
9.2 Amyloidosis Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Amyloidosis Therapeutics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Amyloidosis Therapeutics Market in Asia & Pacific (2019-2029)
10.1 Amyloidosis Therapeutics Market Size
10.2 Amyloidosis Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Amyloidosis Therapeutics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Amyloidosis Therapeutics Market in Europe (2019-2029)
11.1 Amyloidosis Therapeutics Market Size
11.2 Amyloidosis Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Amyloidosis Therapeutics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Amyloidosis Therapeutics Market in MEA (2019-2029)
12.1 Amyloidosis Therapeutics Market Size
12.2 Amyloidosis Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Amyloidosis Therapeutics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Amyloidosis Therapeutics Market (2019-2024)
13.1 Amyloidosis Therapeutics Market Size
13.2 Amyloidosis Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Amyloidosis Therapeutics Market Size by Type
Chapter 14 Global Amyloidosis Therapeutics Market Forecast (2024-2029)
14.1 Amyloidosis Therapeutics Market Size Forecast
14.2 Amyloidosis Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Amyloidosis Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer Inc.
15.1.1 Company Profile
15.1.2 Main Business and Amyloidosis Therapeutics Information
15.1.3 SWOT Analysis of Pfizer Inc.
15.1.4 Pfizer Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.2 ProteoTech Inc.
15.2.1 Company Profile
15.2.2 Main Business and Amyloidosis Therapeutics Information
15.2.3 SWOT Analysis of ProteoTech Inc.
15.2.4 ProteoTech Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.3 Alnylam Pharmaceuticals Inc.
15.3.1 Company Profile
15.3.2 Main Business and Amyloidosis Therapeutics Information
15.3.3 SWOT Analysis of Alnylam Pharmaceuticals Inc.
15.3.4 Alnylam Pharmaceuticals Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.4 Arcturus Therapeutics Inc
15.4.1 Company Profile
15.4.2 Main Business and Amyloidosis Therapeutics Information
15.4.3 SWOT Analysis of Arcturus Therapeutics Inc
15.4.4 Arcturus Therapeutics Inc Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.5 Bellus Health Inc.
15.5.1 Company Profile
15.5.2 Main Business and Amyloidosis Therapeutics Information
15.5.3 SWOT Analysis of Bellus Health Inc.
15.5.4 Bellus Health Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.6 Bsim2
15.6.1 Company Profile
15.6.2 Main Business and Amyloidosis Therapeutics Information
15.6.3 SWOT Analysis of Bsim2
15.6.4 Bsim2 Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.7 Celgene Corporation
15.7.1 Company Profile
15.7.2 Main Business and Amyloidosis Therapeutics Information
15.7.3 SWOT Analysis of Celgene Corporation
15.7.4 Celgene Corporation Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.8 Millennium Pharmaceuticals Inc.
15.8.1 Company Profile
15.8.2 Main Business and Amyloidosis Therapeutics Information
15.8.3 SWOT Analysis of Millennium Pharmaceuticals Inc.
15.8.4 Millennium Pharmaceuticals Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.9 Onyx Pharmaceuticals Inc.
15.9.1 Company Profile
15.9.2 Main Business and Amyloidosis Therapeutics Information
15.9.3 SWOT Analysis of Onyx Pharmaceuticals Inc.
15.9.4 Onyx Pharmaceuticals Inc. Amyloidosis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Amyloidosis Therapeutics Report
Table Data Sources of Amyloidosis Therapeutics Report
Table Major Assumptions of Amyloidosis Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Amyloidosis Therapeutics Picture
Table Amyloidosis Therapeutics Classification
Table Amyloidosis Therapeutics Applications
Table Drivers of Amyloidosis Therapeutics Market
Table Restraints of Amyloidosis Therapeutics Market
Table Opportunities of Amyloidosis Therapeutics Market
Table Threats of Amyloidosis Therapeutics Market
Table COVID-19 Impact For Amyloidosis Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Amyloidosis Therapeutics
Table Cost Structure Analysis of Amyloidosis Therapeutics
Table Key End Users
Table Latest News of Amyloidosis Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Amyloidosis Therapeutics Market
Table Policy of Amyloidosis Therapeutics Market
Table 2019-2029 North America Amyloidosis Therapeutics Market Size
Figure 2019-2029 North America Amyloidosis Therapeutics Market Size and CAGR
Table 2019-2029 North America Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 North America Amyloidosis Therapeutics Key Players Revenue
Table 2019-2024 North America Amyloidosis Therapeutics Key Players Market Share
Table 2019-2029 North America Amyloidosis Therapeutics Market Size by Type
Table 2019-2029 United States Amyloidosis Therapeutics Market Size
Table 2019-2029 Canada Amyloidosis Therapeutics Market Size
Table 2019-2029 Mexico Amyloidosis Therapeutics Market Size
Table 2019-2029 South America Amyloidosis Therapeutics Market Size
Figure 2019-2029 South America Amyloidosis Therapeutics Market Size and CAGR
Table 2019-2029 South America Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 South America Amyloidosis Therapeutics Key Players Revenue
Table 2019-2024 South America Amyloidosis Therapeutics Key Players Market Share
Table 2019-2029 South America Amyloidosis Therapeutics Market Size by Type
Table 2019-2029 Brazil Amyloidosis Therapeutics Market Size
Table 2019-2029 Argentina Amyloidosis Therapeutics Market Size
Table 2019-2029 Chile Amyloidosis Therapeutics Market Size
Table 2019-2029 Peru Amyloidosis Therapeutics Market Size
Table 2019-2029 Asia & Pacific Amyloidosis Therapeutics Market Size
Figure 2019-2029 Asia & Pacific Amyloidosis Therapeutics Market Size and CAGR
Table 2019-2029 Asia & Pacific Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 Asia & Pacific Amyloidosis Therapeutics Key Players Revenue
Table 2019-2024 Asia & Pacific Amyloidosis Therapeutics Key Players Market Share
Table 2019-2029 Asia & Pacific Amyloidosis Therapeutics Market Size by Type
Table 2019-2029 China Amyloidosis Therapeutics Market Size
Table 2019-2029 India Amyloidosis Therapeutics Market Size
Table 2019-2029 Japan Amyloidosis Therapeutics Market Size
Table 2019-2029 South Korea Amyloidosis Therapeutics Market Size
Table 2019-2029 Southeast Asia Amyloidosis Therapeutics Market Size
Table 2019-2029 Australia Amyloidosis Therapeutics Market Size
Table 2019-2029 Europe Amyloidosis Therapeutics Market Size
Figure 2019-2029 Europe Amyloidosis Therapeutics Market Size and CAGR
Table 2019-2029 Europe Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 Europe Amyloidosis Therapeutics Key Players Revenue
Table 2019-2024 Europe Amyloidosis Therapeutics Key Players Market Share
Table 2019-2029 Europe Amyloidosis Therapeutics Market Size by Type
Table 2019-2029 Germany Amyloidosis Therapeutics Market Size
Table 2019-2029 France Amyloidosis Therapeutics Market Size
Table 2019-2029 United Kingdom Amyloidosis Therapeutics Market Size
Table 2019-2029 Italy Amyloidosis Therapeutics Market Size
Table 2019-2029 Spain Amyloidosis Therapeutics Market Size
Table 2019-2029 Belgium Amyloidosis Therapeutics Market Size
Table 2019-2029 Netherlands Amyloidosis Therapeutics Market Size
Table 2019-2029 Austria Amyloidosis Therapeutics Market Size
Table 2019-2029 Poland Amyloidosis Therapeutics Market Size
Table 2019-2029 Russia Amyloidosis Therapeutics Market Size
Table 2019-2029 MEA Amyloidosis Therapeutics Market Size
Figure 2019-2029 MEA Amyloidosis Therapeutics Market Size and CAGR
Table 2019-2029 MEA Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 MEA Amyloidosis Therapeutics Key Players Revenue
Table 2019-2024 MEA Amyloidosis Therapeutics Key Players Market Share
Table 2019-2029 MEA Amyloidosis Therapeutics Market Size by Type
Table 2019-2029 Egypt Amyloidosis Therapeutics Market Size
Table 2019-2029 Israel Amyloidosis Therapeutics Market Size
Table 2019-2029 South Africa Amyloidosis Therapeutics Market Size
Table 2019-2029 Gulf Cooperation Council Countries Amyloidosis Therapeutics Market Size
Table 2019-2029 Turkey Amyloidosis Therapeutics Market Size
Table 2019-2024 Global Amyloidosis Therapeutics Market Size by Region
Table 2019-2024 Global Amyloidosis Therapeutics Market Size Share by Region
Table 2019-2024 Global Amyloidosis Therapeutics Market Size by Application
Table 2019-2024 Global Amyloidosis Therapeutics Market Share by Application
Table 2019-2024 Global Amyloidosis Therapeutics Key Vendors Revenue
Figure 2019-2024 Global Amyloidosis Therapeutics Market Size and Growth Rate
Table 2019-2024 Global Amyloidosis Therapeutics Key Vendors Market Share
Table 2019-2024 Global Amyloidosis Therapeutics Market Size by Type
Table 2019-2024 Global Amyloidosis Therapeutics Market Share by Type
Table 2024-2029 Global Amyloidosis Therapeutics Market Size by Region
Table 2024-2029 Global Amyloidosis Therapeutics Market Size Share by Region
Table 2024-2029 Global Amyloidosis Therapeutics Market Size by Application
Table 2024-2029 Global Amyloidosis Therapeutics Market Share by Application
Table 2024-2029 Global Amyloidosis Therapeutics Key Vendors Revenue
Figure 2024-2029 Global Amyloidosis Therapeutics Market Size and Growth Rate
Table 2024-2029 Global Amyloidosis Therapeutics Key Vendors Market Share
Table 2024-2029 Global Amyloidosis Therapeutics Market Size by Type
Table 2024-2029 Amyloidosis Therapeutics Global Market Share by Type

Companies Mentioned

  • Pfizer Inc.
  • ProteoTech Inc.
  • Alnylam Pharmaceuticals Inc.
  • Arcturus Therapeutics Inc
  • Bellus Health Inc.
  • Bsim2
  • Celgene Corporation
  • Millennium Pharmaceuticals Inc.
  • Onyx Pharmaceuticals Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Amyloidosis - Global Clinical Trials Review, 2024 - Product Image

Amyloidosis - Global Clinical Trials Review, 2024

  • Clinical Trials
  • 278 Pages
  • Global
From
Amyloidosis Treatment - Global Strategic Business Report - Product Image

Amyloidosis Treatment - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Transthyretin Amyloidosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Transthyretin Amyloidosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 120 Pages
  • Global
From
Transthyretin Amyloidosis Treatment Global Market Report 2024 - Product Image

Transthyretin Amyloidosis Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Cardiac Amyloidosis - Pipeline Insight, 2024 - Product Image

Cardiac Amyloidosis - Pipeline Insight, 2024

  • Drug Pipelines
  • 80 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.